Severe aortopathy due to fibulin-4 deficiency

Molecular insights, surgical strategy, and a review of the literature

Camden Hebson, Karlene Coleman, Martha Clabby, Denver Sallee, Suma Shankar, Bart Loeys, Lut Van Laer, Brian Kogon

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Mutations in the EFEMP2 (alias FBLN4) gene, which encodes the extracellular matrix protein fibulin-4, lead to severe aortopathy with aneurysm formation and vascular tortuosity. The disease phenotype, termed autosomal recessive cutis laxa type 1B (ARCL 1B), is rare among heritable connective tissue diseases but becomes more likely when noting family consanguinity and loose, inelastic skin in the patient. Our patient presented with an intercurrent illness exacerbating upper airway obstruction due to compression from a large aortic aneurysm. Genetic testing eventually revealed the causative mutation. She was initially treated with an angiotensin II receptor blocker and beta-blocker and eventually underwent total thoracic aortic replacement via a two-stage elephant trunk-type procedure. She recovered well and is currently asymptomatic but will require lifetime follow-up due to residual vascular tortuosity and aneurysm risk. Conclusion: Better understanding of the importance of transforming growth factor beta signaling in the pathophysiology of aortopathies such as ARCL 1B has led to targeted medical therapies. Specific surgical techniques can lead to optimal outcomes in these patients.

Original languageEnglish (US)
Pages (from-to)671-675
Number of pages5
JournalEuropean Journal of Pediatrics
Volume173
Issue number5
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Aneurysm
Blood Vessels
Consanguinity
Mutation
Connective Tissue Diseases
Aortic Aneurysm
Extracellular Matrix Proteins
Angiotensin Receptor Antagonists
Genetic Testing
Airway Obstruction
Transforming Growth Factor beta
Thorax
Phenotype
Skin
Genes
fibulin-4
Cutis Laxa, Autosomal Recessive, Type I
Therapeutics

Keywords

  • Aortopathy
  • Cutis laxa
  • Elephant trunk procedure
  • FBLN4
  • Fibulin-4
  • TGFβ signaling

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Severe aortopathy due to fibulin-4 deficiency : Molecular insights, surgical strategy, and a review of the literature. / Hebson, Camden; Coleman, Karlene; Clabby, Martha; Sallee, Denver; Shankar, Suma; Loeys, Bart; Van Laer, Lut; Kogon, Brian.

In: European Journal of Pediatrics, Vol. 173, No. 5, 01.01.2014, p. 671-675.

Research output: Contribution to journalArticle

Hebson, Camden ; Coleman, Karlene ; Clabby, Martha ; Sallee, Denver ; Shankar, Suma ; Loeys, Bart ; Van Laer, Lut ; Kogon, Brian. / Severe aortopathy due to fibulin-4 deficiency : Molecular insights, surgical strategy, and a review of the literature. In: European Journal of Pediatrics. 2014 ; Vol. 173, No. 5. pp. 671-675.
@article{84f8b95c1bd349ff80ea5a1fcd52e6c6,
title = "Severe aortopathy due to fibulin-4 deficiency: Molecular insights, surgical strategy, and a review of the literature",
abstract = "Mutations in the EFEMP2 (alias FBLN4) gene, which encodes the extracellular matrix protein fibulin-4, lead to severe aortopathy with aneurysm formation and vascular tortuosity. The disease phenotype, termed autosomal recessive cutis laxa type 1B (ARCL 1B), is rare among heritable connective tissue diseases but becomes more likely when noting family consanguinity and loose, inelastic skin in the patient. Our patient presented with an intercurrent illness exacerbating upper airway obstruction due to compression from a large aortic aneurysm. Genetic testing eventually revealed the causative mutation. She was initially treated with an angiotensin II receptor blocker and beta-blocker and eventually underwent total thoracic aortic replacement via a two-stage elephant trunk-type procedure. She recovered well and is currently asymptomatic but will require lifetime follow-up due to residual vascular tortuosity and aneurysm risk. Conclusion: Better understanding of the importance of transforming growth factor beta signaling in the pathophysiology of aortopathies such as ARCL 1B has led to targeted medical therapies. Specific surgical techniques can lead to optimal outcomes in these patients.",
keywords = "Aortopathy, Cutis laxa, Elephant trunk procedure, FBLN4, Fibulin-4, TGFβ signaling",
author = "Camden Hebson and Karlene Coleman and Martha Clabby and Denver Sallee and Suma Shankar and Bart Loeys and {Van Laer}, Lut and Brian Kogon",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00431-013-2217-y",
language = "English (US)",
volume = "173",
pages = "671--675",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Severe aortopathy due to fibulin-4 deficiency

T2 - Molecular insights, surgical strategy, and a review of the literature

AU - Hebson, Camden

AU - Coleman, Karlene

AU - Clabby, Martha

AU - Sallee, Denver

AU - Shankar, Suma

AU - Loeys, Bart

AU - Van Laer, Lut

AU - Kogon, Brian

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Mutations in the EFEMP2 (alias FBLN4) gene, which encodes the extracellular matrix protein fibulin-4, lead to severe aortopathy with aneurysm formation and vascular tortuosity. The disease phenotype, termed autosomal recessive cutis laxa type 1B (ARCL 1B), is rare among heritable connective tissue diseases but becomes more likely when noting family consanguinity and loose, inelastic skin in the patient. Our patient presented with an intercurrent illness exacerbating upper airway obstruction due to compression from a large aortic aneurysm. Genetic testing eventually revealed the causative mutation. She was initially treated with an angiotensin II receptor blocker and beta-blocker and eventually underwent total thoracic aortic replacement via a two-stage elephant trunk-type procedure. She recovered well and is currently asymptomatic but will require lifetime follow-up due to residual vascular tortuosity and aneurysm risk. Conclusion: Better understanding of the importance of transforming growth factor beta signaling in the pathophysiology of aortopathies such as ARCL 1B has led to targeted medical therapies. Specific surgical techniques can lead to optimal outcomes in these patients.

AB - Mutations in the EFEMP2 (alias FBLN4) gene, which encodes the extracellular matrix protein fibulin-4, lead to severe aortopathy with aneurysm formation and vascular tortuosity. The disease phenotype, termed autosomal recessive cutis laxa type 1B (ARCL 1B), is rare among heritable connective tissue diseases but becomes more likely when noting family consanguinity and loose, inelastic skin in the patient. Our patient presented with an intercurrent illness exacerbating upper airway obstruction due to compression from a large aortic aneurysm. Genetic testing eventually revealed the causative mutation. She was initially treated with an angiotensin II receptor blocker and beta-blocker and eventually underwent total thoracic aortic replacement via a two-stage elephant trunk-type procedure. She recovered well and is currently asymptomatic but will require lifetime follow-up due to residual vascular tortuosity and aneurysm risk. Conclusion: Better understanding of the importance of transforming growth factor beta signaling in the pathophysiology of aortopathies such as ARCL 1B has led to targeted medical therapies. Specific surgical techniques can lead to optimal outcomes in these patients.

KW - Aortopathy

KW - Cutis laxa

KW - Elephant trunk procedure

KW - FBLN4

KW - Fibulin-4

KW - TGFβ signaling

UR - http://www.scopus.com/inward/record.url?scp=84900835560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900835560&partnerID=8YFLogxK

U2 - 10.1007/s00431-013-2217-y

DO - 10.1007/s00431-013-2217-y

M3 - Article

VL - 173

SP - 671

EP - 675

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 5

ER -